Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrin C Bergheanu

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Heart (British Cardiac Society)|November 18, 2008
Statins: established indications and controversial subgroupsJ Wouter Jukema, Sandrin C Bergheanu
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2011
Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic reviewTarek A N Ahmed, Sandrin C Bergheanu, Theo Stijnen, et al.
Current Medical Research and Opinion|August 25, 2010
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parametersIoannis K Karalis, Sandrin C Bergheanu, Ron Wolterbeek, et al.
Clinical Pharmacology and Therapeutics|April 20, 2018
A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular DiseaseMathijs C Bodde, Paul Welsh, Sandrin C Bergheanu, et al.
Current Medical Research and Opinion|July 29, 2008
Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statinsSandrin C Bergheanu, Theo Reijmers, Aeilko H Zwinderman, et al.
Heart and Vessels|November 6, 2010
The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stentsSandrin C Bergheanu, Douwe Pons, Bas L van der Hoeven, et al.
The American Journal of Cardiology|March 10, 2009
Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary interventionAyman K M Hassan, Sandrin C Bergheanu, Hosam Hasan-Ali, et al.
European Heart Journal|January 23, 2009
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosisAyman K M Hassan, Sandrin C Bergheanu, Theo Stijnen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention studyJael Z Atary, Sandrin C Bergheanu, Bas L van der Hoeven, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention studyBas L van der Hoeven, Su-San Liem, Jouke Dijkstra, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Heart (British Cardiac Society)|November 18, 2008
Statins: established indications and controversial subgroupsJ Wouter Jukema, Sandrin C Bergheanu
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 19, 2011
Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic reviewTarek A N Ahmed, Sandrin C Bergheanu, Theo Stijnen, et al.
Current Medical Research and Opinion|August 25, 2010
Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parametersIoannis K Karalis, Sandrin C Bergheanu, Ron Wolterbeek, et al.
Clinical Pharmacology and Therapeutics|April 20, 2018
A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High-Sensitivity Cardiac Troponin-I in Subjects With Stable Cardiovascular DiseaseMathijs C Bodde, Paul Welsh, Sandrin C Bergheanu, et al.
Current Medical Research and Opinion|July 29, 2008
Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statinsSandrin C Bergheanu, Theo Reijmers, Aeilko H Zwinderman, et al.
Heart and Vessels|November 6, 2010
The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stentsSandrin C Bergheanu, Douwe Pons, Bas L van der Hoeven, et al.
The American Journal of Cardiology|March 10, 2009
Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary interventionAyman K M Hassan, Sandrin C Bergheanu, Hosam Hasan-Ali, et al.
European Heart Journal|January 23, 2009
Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosisAyman K M Hassan, Sandrin C Bergheanu, Theo Stijnen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention studyJael Z Atary, Sandrin C Bergheanu, Bas L van der Hoeven, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention studyBas L van der Hoeven, Su-San Liem, Jouke Dijkstra, et al.
Pageof 2